Key facts: Aehr record Q1; $150M outlook; FOX-XP eval; 12+ prospects
Aehr Test Systems reported record Q1 2027 revenue of $33M, up 200% YoY, with $46.7M in bookings. It raised its fiscal-year outlook to $150M. A major chip supplier plans to evaluate its FOX-XP test cell in Taiwan. The company has over a dozen potential customers. Cash reserves were $105.1M as of September 25, 2026.
How this was made
The 30-second read
Why it matters
The record Q1 and raised FY outlook suggest a significant upside catalyst for the stock.
Market read
First earnings release with strong growth and guidance lift, offering a medium‑term bullish catalyst.
What to watch
Potential supply‑chain constraints for burn‑in test cells in Taiwan.
Background
AEHR is a micro‑cap provider of semiconductor test systems serving AI processor manufacturers.
Ticker impact
AEHR reported record Q1 2027 revenue of $33M and raised FY outlook to $150M, a fresh earnings disclosure.
likely upward pressure as market prices in higher revenue outlook
First report of earnings with 200% YoY revenue growth and a three‑fold FY revenue target.
Market effects
Highlights accelerating demand for AI test equipment across silicon photonics and wide‑bandgap materials.
Positive for US semiconductor test equipment suppliers.
Modest; primarily affects niche AI processor test market.
Counterpoint
Growth may be unsustainable; cash burn could rise if bookings slow.
Key entities
- companyAehr Test Systems
Provider of test equipment for AI processors and advanced semiconductor materials.
